Target intelligence / Profile preview

Mitochondrial ribosomal protein L13 (MRPL13)

Target
MRPL13
Molecular classification
Other (structural protein of ribosome, mitochondrial ribosomal protein)
01

Overview

Mitochondrial ribosomal protein L13 (MRPL13) is a nuclear-encoded protein that is a critical component of the 39S large subunit of the mitochondrial ribosome in eukaryotes[4][9][1]. It plays a central role in mitochondrial protein synthesis by contributing to the assembly and function of the mitoribosome, which is distinct in composition and structure from prokaryotic ribosomes, notably lacking 5S rRNA and having a higher protein-to-rRNA ratio[4][1][9][10]. MRPL13 is essential for maintaining mitochondrial function and integrity, as evidenced in model organisms, and its loss disrupts mitochondrial membrane potential, protein synthesis, and cellular energy production[2]. In human disease, MRPL13 has been associated with enhanced mitochondrial performance, protection against apoptosis, and with promoting tumor growth in recent research[7]. No direct drugs target human MRPL13, but it is indirectly relevant in malarial parasites for the action of certain mitochondrial-acting antimalarials[2]. The gene is located on chromosome 8 in humans[1][11].

Other names
Large ribosomal subunit protein uL13mL13mtMRP-L13L13L13ARPL13RPML13uL13m39S ribosomal protein L13, mitochondrial
02

Mechanism of action

Not established for drugs directly interacting with MRPL13, but ablation of MRPL13 in malaria parasites increases sensitivity to mitochondrial-acting drugs (e.g., proguanil)[2].

03

Biological functions

Protein synthesis within mitochondriaStructural constituent of ribosomeRNA binding
04

Disease associations

Cancer (implicated in mitochondrial function, tumor progression, and apoptosis in recent research[7])Other (Essential for mitochondrial integrity in Plasmodium falciparum—vital for parasite viability[2])Mitochondrial diseases (by inference, as it is crucial for mitochondrial protein synthesis and function)
05

Safety considerations

None directly notedDisruption leads to loss of mitochondrial function, potential cell death, and may promote disease states if mitochondrial translation is impaired
06

Interacting drugs

None directly documented
07

Biomarkers

None currently established for patient selection or efficacy monitoring regarding human MRPL13

Beyond the preview

Go deeper on Mitochondrial ribosomal protein L13 (MRPL13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein L13 (MRPL13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call